Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition containing bacterium belonging to genus bifidobacterium as active ingredient

A technology of bifidobacteria and active ingredients, which can be used in medical preparations containing active ingredients, bacteria, antibacterial drugs, etc., can solve problems such as poor prognosis of esophageal cancer

Pending Publication Date: 2020-07-31
MORINAGA MILK IND CO LTD
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] In addition, it was reported that the presence of Fusobacterium was confirmed in 325 cases of esophageal cancer tissues, and as a resu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition containing bacterium belonging to genus bifidobacterium as active ingredient
  • Composition containing bacterium belonging to genus bifidobacterium as active ingredient
  • Composition containing bacterium belonging to genus bifidobacterium as active ingredient

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to View More

PUM

No PUM Login to View More

Abstract

The present invention addresses the problem of providing a composition for preventing the adsorption of a bacterium belonging to the genus Fusobacterium to a mucosal cell; and a pharmaceutical composition and a food or beverage composition for preventing or treating a disease or condition that is associated with the inflammation of a mucosal cell and is selected from the group consisting of ulcerative colitis, colorectal cancer, esophagus cancer, premature birth and periodontal disease. The problem can be solved by the composition for preventing the adsorption of a bacterium belonging to the genus Fusobacterium to a mucosal cell, which contains a bacterium belonging to the genus Bifidobacterium as an active ingredient; and the pharmaceutical composition and the food or beverage compositionfor preventing or treating a disease or condition that is associated with the inflammation of a mucosal cell and is selected from the group consisting of ulcerative colitis, colorectal cancer, esophagus cancer, premature birth and periodontal disease, which contains a bacterium belonging to the genus Bifidobacterium as an active ingredient.

Description

technical field [0001] The present invention relates to a composition for inhibiting the adsorption of Fusobacterium bacteria to mucosal cells. In addition, the present invention relates to a product selected from the group consisting of ulcerative colitis, colorectal cancer, esophagus cancer, premature birth and periodontal disease, which contains bacteria of the genus Bifidobacterium as an active ingredient and is used for preventing or treating inflammation caused by mucosal cells. A pharmaceutical composition and a food composition for a disease or symptom in the present invention. Background technique [0002] Bacteria belonging to the genus Bifidobacterium are known to be effective in the prevention, treatment, improvement, etc. of human diseases and symptoms. [0003] For example, Bifidobacterium bifidum G9-1 is known to be effective in the prevention or treatment of 5-fluorouracil-induced intestinal diseases (Patent Document 1). [0004] In addition, it is known th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/745A23L33/135A61P1/02A61P1/04A61P15/06A61P29/00A61P31/04A61P35/00C12N1/20
CPCA23L33/135A61K35/745A61P1/02A61P1/04A61P15/06A61P29/00A61P31/04A61P35/00C12N1/20C12N1/205C12R2001/01A61K35/20A61K2300/00
Inventor 吉本真小田卷俊孝
Owner MORINAGA MILK IND CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products